Pharmaceutical considerations of nitroglycerin

Drug Intelligence & Clinical Pharmacy
A YacobiD M Baaske

Abstract

During the past few years, there have been rapid changes in the pharmaceutical uses of nitroglycerin. New dosage forms and new delivery systems have become available, which have resulted in potential confusion to all concerned with the proper use of these systems. The goal of this review is to prevent confusion and to bring all the relevant information together. The various analytical techniques available for quality control of the dosage forms and for the study of the pharmacokinetics are reviewed, with the intent of enabling the reader to identify pertinent references rapidly. The interaction of nitroglycerin with packaging and plastic delivery devices is also reviewed so that the reader can make informed choices. Finally, the clinical pharmacy and pharmacokinetics are reviewed so as to bring the reader up to date in that area. After reading this article, the areas of nitroglycerin research that still need to be explored should be apparent.

References

Aug 12, 1978·Lancet·P A CossumG W Boyd
Oct 1, 1978·American Heart Journal·J E Cottrell, H Turndorf
Mar 1, 1979·Circulation·P W ArmstrongG S Marks
Mar 1, 1979·Circulation·J Y Wei, P R Reid
Feb 1, 1979·Journal of Pharmaceutical Sciences·W G Crouthamel, B Dorsch
Apr 1, 1979·Journal of Pharmaceutical Sciences·D M BaaskeA H Amann
Sep 1, 1979·Journal of Pharmaceutical Sciences·P H YuenA M Burkman
Sep 1, 1979·Journal of Pharmaceutical Sciences·R A Morrison, H L Fung
Apr 1, 1977·British Journal of Clinical Pharmacology·H P BlumenthalS K Yap
Sep 1, 1977·Journal of Pharmaceutical Sciences·M J PikalB Rutherford
Feb 1, 1978·The American Journal of Medicine·J Abrams
Apr 1, 1978·Journal of Pharmaceutical Sciences·P S YapH L Fung
Jan 1, 1975·Circulation·J T FlahertyB Pitt
Jan 1, 1975·Journal of Pharmaceutical Sciences·D P PageM T Randall
Dec 1, 1975·Toxicology and Applied Pharmacology·J R Hodgson, C C Lee
Jul 1, 1976·Anesthesiology·J A KaplanE L Jones
Sep 1, 1976·Journal of Pharmaceutical Sciences·M J PikalL F Ellis
May 1, 1973·Journal of Pharmaceutical Sciences·M T Rosseel, M G Bogaert
Jan 1, 1973·Journal of Pharmaceutical Sciences·S A Fusari
Apr 1, 1973·Journal of Pharmaceutical Sciences·H L FungC T Rhodes
Aug 1, 1965·Biochemical Pharmacology·P Needleman, J C Krantz
May 1, 1968·Journal of Pharmaceutical Sciences·D Banes
Oct 1, 1968·Biochemical Pharmacology·F J DiCarloR L Gala
Jun 1, 1969·Proceedings of the Society for Experimental Biology and Medicine·F J DiCarlo, M D Melgar
Sep 1, 1981·Journal of Pharmaceutical Sciences·E F McNiffH L Fung
Apr 1, 1980·The Journal of Pharmacy and Pharmacology·M S RobertsG W Boyd
Sep 1, 1980·Journal of Pharmaceutical Sciences·L Gelber
May 1, 1980·Canadian Journal of Physiology and Pharmacology·J A ArmstrongP W Armstrong
Jul 1, 1981·Journal of Pharmaceutical Sciences·A W MalickR G Stoll
Jul 1, 1981·Journal of Pharmaceutical Sciences·P A Cossum, M S Roberts
Dec 1, 1981·Journal of Pharmaceutical Sciences·S SvedI J McGilveray
Jan 1, 1982·Journal of Pharmaceutical Sciences·A H ScheifeL Shargel
Apr 1, 1982·Journal of Pharmaceutical Sciences·A H Amann, D M Baaske
Apr 1, 1982·Drug Intelligence & Clinical Pharmacy·J JacobiM B Howie
Jul 1, 1964·Journal of Pharmaceutical Sciences·F K BELL

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.